Melinda Posted March 20, 2004 Share Posted March 20, 2004 The web address for this is: http://www.mskcc.org/mskcc/html/14468.cfm ------------------------------------------------------------------------------------- Here you can find a continually updated listing of Memorial Sloan-Kettering's current clinical trials for lung cancer. To learn more about a study, choose from the list below. -------------------------------------------------------------------------------- 3-D Reconstruction of CT Scan Images in the Evaluation of Non-Specific Pulmonary Nodules Feinstein Marc B M.D. [Protocol 03-039] Acupuncture for Chronic Shortness of Breath in Cancer Patients Cassileth Barrie Ph.D. [Protocol 01-096] DNA Repair & Genetic Susceptibility to Lung Cancer Rusch Valerie M.D. [Protocol 03-003] Dosing Study of N-Propionylated Polysialic Acid Vaccine in Patients with Small Cell Lung Cancer Who Have Achieved a Major Response to Initial Therapy Krug Lee M M.D. [Protocol 02-097] Low-Dose Computed Tomographic (CT) Screening for Detection of Early Lung Cancer Heelan Robert M.D. [Protocol 01-086] Methylated Genes in Blood as Biomarkers for Advanced Lung Cancer Kris Mark M.D. [Protocol 02-111] Methylated Genes in Blood as Biomarkers for Early-Stage Non-Small Cell Lung Cancer Rusch Valerie M.D. [Protocol 02-112] Phase I/II Trial of OSI-774 (Erlotinib, Tarceva) in Patients with Advanced Non-Small Cell Lung Cancer Miller Vincent A M.D. [Protocol 02-115] Phase I/II Trial of Weekly ABI-007 in Patients with Advanced Non-Small Cell Lung Cancer Who Have Not Had Chemotherapy for Metastatic Disease Rizvi Naiyer A M.D. [Protocol 03-111] Phase II Study of KOS-862 in Patients with Non-Small Cell Lung Cancer that has Progressed Following Initial Therapy for Advanced or Metastatic Disease Rizvi Naiyer A M.D. [Protocol 03-134] Phase II Study of Soblidotin (TZT-1027) in Patients with Progressive Locally Advanced or Metastatic Non-Small Cell Lung Cancer Rizvi Naiyer A M.D. [Protocol 03-016] Phase II Study of ZD6474 and ZD1839 (Iressa) as Second-Line Therapy for Locally Advanced or Metastatic Non-Small Cell Lung Cancer Rizvi Naiyer A M.D. [Protocol 03-090] Phase II Trial of Cisplatin, Gemcitabine & Daily Erlotinib (OSI774, Tarceva) in Patients with Locally Advanced Non-Small Cell Cancer Miller Vincent A M.D. [Protocol 02-071] Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.